Insmed (INSM) Tax Rate Growth (1y) (2012 - 2026)

Insmed (INSM) Tax Rate Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,320.50 Bn 66,320.21 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.93 Bn 468.14 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.22 Bn 114.98 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.96 Bn 61.21 Bn 3.31 Bn
7 Belite Bio 62.66 Bn 62.66 Bn -
8 Argenx Se 56.07 Bn 50.89 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.60 Bn 34.59 Bn 959.66 Mn
10 Insmed 22.92 Bn 21.69 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -57.00
Dec 31, 2025 10.00
Sep 30, 2025 11.00
Jun 30, 2025 -12.00
Mar 31, 2025 2.00
Dec 31, 2024 -2.00
Sep 30, 2024 -12.00
Jun 30, 2024 -6.00
Mar 31, 2024 -7.00
Dec 31, 2023 -46.00
Sep 30, 2023 -6.00
Jun 30, 2023 32.00
Mar 31, 2023 11.00
Dec 31, 2022 -15.00
Sep 30, 2022 -252.00
Jun 30, 2022 -1.00
Mar 31, 2022 -19.00
Dec 31, 2021 67.00
Sep 30, 2021 274.00
Jun 30, 2021 14.00